- $647.06m
- $1.07bn
- $903.46m
- 67
- 95
- 77
- 93
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 559 | 524 | 545 | 918 | 903 |
Cost of Revenue | |||||
Gross Profit | 324 | 321 | 257 | 451 | 438 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 518 | 760 | 527 | 680 | 812 |
Operating Profit | 41.1 | -236 | 18.1 | 239 | 91.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 6.99 | -270 | -14.1 | 208 | 55.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 43.5 | -263 | -15.5 | 250 | 37.4 |
Net Income Before Extraordinary Items | |||||
Net Income | 43.5 | -263 | -15.5 | 250 | 37.4 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 43.5 | -263 | -15.5 | 250 | 37.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.976 | -0.891 | -0.172 | 3.06 | 0.587 |
Dividends per Share | |||||
Special Dividends per Share |